MedTrace Logo

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

NCT03205137 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-06-28

No results posted yet for this study

Summary

The primary objective of this study is to compare the medication adherence measured by PDC of patients with FDC or double-pill combination therapy in real-world Japanese therapeutic practice.The further objective of this study is how much influence the background of patients to the adherence.

Conditions

Interventions

DRUG

subjects treated with telmisartan/hydrochlorothiazide

subjects treated with telmisartan/hydrochlorothiazide

DRUG

Subjects treated with Telmisartan and amlodipine

Subjects treated with Telmisartan and amlodipine

DRUG

subjects treated with Telmisartan+hydrochlorothiazide double-pill combination group

subjects treated with Telmisartan+hydrochlorothiazide double-pill combination group

DRUG

subjects treated with telmisartan+amlodipine double pill

subjects treated with telmisartan+amlodipine double pill

Sponsors & Collaborators

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2022-07-11
Completion
2022-07-11

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03205137 on ClinicalTrials.gov